Question 78

The prescription appears to contain a look-alike/sound-alike error.

The pharmacy technician should alert the pharmacist because the prescribed medication, levetiracetam, is not indicated for the treatment of pneumonia, suggesting a potential mix-up with a similar-sounding medication.

A) the prescription appears to contain a look-alike/sound-alike error.

This option is correct because levetiracetam is primarily an anticonvulsant used for seizure disorders, not for pneumonia. Such confusion could arise from mixing it up with another medication that is appropriate for pneumonia, necessitating a closer look by the pharmacist.

B) levetiracetam requires special handling.

This option is incorrect as levetiracetam does not require special handling. It is typically dispensed like any other oral medication, and therefore this reason would not warrant alerting the pharmacist in this context.

C) the prescription exceeds the maximum recommended daily dose.

This option is incorrect because the prescribed dose of 500 mg once a day is within the normal dosing range for levetiracetam. The maximum daily dose for levetiracetam can be higher depending on the condition being treated, making this option irrelevant to the situation.

D) levetiracetam is subject to a REMS program.

This option is incorrect as levetiracetam is not subject to a Risk Evaluation and Mitigation Strategy (REMS) program. REMS programs are generally associated with medications that have significant risks, which does not apply to levetiracetam.

Conclusion

The identification of a look-alike/sound-alike error is crucial in pharmacy practice to prevent medication errors. Since levetiracetam is not appropriate for treating pneumonia, it is essential for the pharmacy technician to notify the pharmacist immediately, whereas the other options do not apply to this situation. This highlights the importance of understanding medication indications and potential errors in prescription processing.